Sian Fereday

14PUBLICATIONS
219CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 06, 2026
Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Nov 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Dale Garsed, Tibor Zwimpfer, Sian Fereday

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

|Jun 20, 2023
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.

Karolin Heinze, Evan S Cairns, Shelby Thornton

|Feb 28, 2023
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.

Nikki L Burdett, Madelynne O Willis, Kathryn Alsop

Pageof 3

Frequent Collaborators

9 joint publications

Dale W Garsed

7 joint publications

Dinuka Ariyaratne

7 joint publications

Elizabeth L Christie

7 joint publications

Anna DeFazio